These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10250992)

  • 1. Price-cutting in antibiotics causes HPM indexes to drift.
    Hosp Purch Manage; 1981 May; 6(5):9-10. PubMed ID: 10250992
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug price decline continues as HPM index drops 3 points.
    Hosp Purch Manage; 1985 May; 10(5):12-3. PubMed ID: 10317596
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacoeconomic principles and methods: an introduction for hospital pharmacists.
    Sanchez LA
    Hosp Pharm; 1994 Aug; 29(8):774, 777-9. PubMed ID: 10135744
    [No Abstract]   [Full Text] [Related]  

  • 4. DRG management. Many factors affect drug treatment costs.
    Mendenhall S
    Mod Healthc; 1985 Feb; 15(4):98-100. PubMed ID: 10273620
    [No Abstract]   [Full Text] [Related]  

  • 5. Researchers begin linking cost with performance to test new drugs' value.
    Hospitals; 1982 Apr; 56(7):54, 57. PubMed ID: 6800913
    [No Abstract]   [Full Text] [Related]  

  • 6. Using pharmaceutical cost analyses for decision making.
    U'Ren NA
    Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832
    [No Abstract]   [Full Text] [Related]  

  • 7. No surprises: brand-name prices up 4% while antibiotic and penicillin indexes fall.
    Hosp Mater Manage; 1988 Jun; 13(6):11. PubMed ID: 10318084
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating the real costs of drug therapy.
    Halpern GA
    Am J Hosp Pharm; 1989 Dec; 46(12):2460-1. PubMed ID: 2603875
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring hospital medicine expenditure.
    Hughes G
    Hosp Health Serv Rev; 1981 Oct; 77(9):285-7. PubMed ID: 10253429
    [No Abstract]   [Full Text] [Related]  

  • 10. The risks of substitution of therapeutic modalities by cheaper and sometimes less effective agents.
    Brook I
    Arch Intern Med; 1990 Mar; 150(3):688-9. PubMed ID: 2310291
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacy. Target drug programs can reduce some costs and avoid others.
    Cost Containment; 1984 Aug; 6(16):3-6. PubMed ID: 10267698
    [No Abstract]   [Full Text] [Related]  

  • 12. Emphasize the patient, not the cost.
    Kendall JD; Lane SM
    Am J Hosp Pharm; 1994 Feb; 51(3):410. PubMed ID: 8160704
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring the cost of drugs.
    Wittrick A
    Health Serv J; 1987 Jun; 97(5054):678. PubMed ID: 10312121
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does a more rational antibiotic policy lead to cost control?].
    Boerema JB; Goris RJ; Hekster YA
    Ned Tijdschr Geneeskd; 1980 Apr; 124(14):498-502. PubMed ID: 7374811
    [No Abstract]   [Full Text] [Related]  

  • 15. Tips and techniques: controlling drug costs.
    Gallina JN
    Curr Concepts Hosp Pharm Manage; 1988; 10(3):13. PubMed ID: 10288228
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost analysis with institutional data.
    Hopkins L
    J Pharm Mark Manage; 1987; 2(2):33-47. PubMed ID: 10312560
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Price Index declines as prices weaken for older drugs.
    Hosp Mater Manage; 1986 May; 11(5):21-2. PubMed ID: 10277138
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug price inflation slows but competition is limited.
    Hosp Purch Manage; 1983 Aug; 8(8):13-4. PubMed ID: 10261667
    [No Abstract]   [Full Text] [Related]  

  • 19. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 20. Three pharmacy indexes rise in 4th quarter.
    Hosp Mater Manage; 1989 Apr; 14(4):14. PubMed ID: 10292834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.